Healthtech funding in April 2019
European Healthtech startup funding raised during April 2019.
In April 2019, 104 European Healthtech companies closed 104 funding rounds and raised €811M in equity funding (excluding debt and grants). France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€811M
excl. debt & grants
Funding rounds
104
Companies
104
Top country
France
Rank among sectors
#6
5.0% of sector funding
Top-10 round share
48.9%
of disclosed capital
Top countries
by € raisedHealthtech — top countries by capital, April 2019 — interactive chart.
Data table
| Healthtech — top countries by capital, April 2019 | |
|---|---|
| France | €172M |
| Belgium | €151M |
| Israel | €90M |
| Poland | €88M |
| UK | €75M |
| Netherlands | €50M |
| Ireland | €41M |
| Italy | €30M |
Stage mix
by € raisedHealthtech — stage mix, April 2019 — interactive chart.
Data table
| Healthtech — stage mix, April 2019 | |
|---|---|
| Series B | €257M |
| Series A | €217M |
| Other | €174M |
| Series D+ | €120M |
| Seed | €29M |
| Series C | €14M |
| Pre-Seed | €596k |
Top deals
largest disclosed rounds in April 2019| Company | Stage | Date | Amount |
|---|---|---|---|
| docplanner | Series D+ | Apr 2019 | €80M |
| Bioserenity | Series B | Apr 2019 | €65M |
| Promethera Biosciences | Series D+ | Apr 2019 | €40M |
| Imcyse | Series B | Apr 2019 | €35M |
| DNA Script | Series B | Apr 2019 | €34M |
| Confo Therapeutics | Series A | Apr 2019 | €30M |
| Micreos | Other | Apr 2019 | €30M |
| Zava | Series A | Apr 2019 | €28M |
| DayTwo | Series B | Apr 2019 | €28M |
| LetsGetChecked | Series B | Apr 2019 | €27M |
| AIDoc | Series B | Apr 2019 | €24M |
| Agomab Therapeutics | Series A | Apr 2019 | €21M |
| Lifen | Series B | Apr 2019 | €20M |
| Qare | Series B | Apr 2019 | €20M |
| Rapid Medical | Other | Apr 2019 | €18M |
Top investors
most active in April 2019, by deal count- Bpifrance2 deals
- Capital Cell2 deals
- Enterprise Ireland2 deals
- Kamet Ventures2 deals
- University of Cambridge Enterprise2 deals
- 24Haymarket1 deals
- ACT Venture Capital1 deals
- Advent France Biotechnology1 deals
- aMoon Fund1 deals
- Arbevel1 deals